{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T19:05:56Z","timestamp":1770145556430,"version":"3.49.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T00:00:00Z","timestamp":1734393600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T00:00:00Z","timestamp":1734393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s13346-024-01760-1","type":"journal-article","created":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T17:32:45Z","timestamp":1734456765000},"page":"2676-2693","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Hydrophobic ion pairing: lipophilicity improvement of anionic macromolecules by divalent cation mediated complex formation"],"prefix":"10.1007","volume":"15","author":[{"given":"Sera","family":"Lindner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabrizio","family":"Ricci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ren\u00e9","family":"Holm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dajun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathaniel","family":"Washburn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cecilia Bohns","family":"Michalowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giustino","family":"Di Pretoro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4187-8277","authenticated-orcid":false,"given":"Andreas","family":"Bernkop-Schn\u00fcrch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,17]]},"reference":[{"issue":"8","key":"1760_CR1","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1016\/J.APSB.2021.04.001","volume":"11","author":"Q Zhu","year":"2021","unstructured":"Zhu Q, Chen Z, Paul PK, Lu Y, Wu W, Qi J. Oral delivery of proteins and peptides: Challenges, status quo and future perspectives. Acta Pharm Sin B. 2021;11(8):2416\u201348. https:\/\/doi.org\/10.1016\/J.APSB.2021.04.001.","journal-title":"Acta Pharm Sin B"},{"key":"1760_CR2","doi-asserted-by":"publisher","first-page":"618411","DOI":"10.3389\/FPHAR.2021.618411","volume":"12","author":"MS Alqahtani","year":"2021","unstructured":"Alqahtani MS, Kazi M, Alsenaidy MA, Ahmad MZ. Advances in Oral Drug Delivery. Front Pharmacol. 2021;12:618411. https:\/\/doi.org\/10.3389\/FPHAR.2021.618411.","journal-title":"Front Pharmacol"},{"issue":"4","key":"1760_CR3","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/nrd1067","volume":"2","author":"M Goldberg","year":"2003","unstructured":"Goldberg M, Gomez-Orellana I. Challenges for the oral delivery of macromolecules. Nat Rev Drug Discov. 2003;2(4):289\u201395. https:\/\/doi.org\/10.1038\/nrd1067.","journal-title":"Nat Rev Drug Discov"},{"key":"1760_CR4","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/J.ADDR.2016.06.005","volume":"106","author":"S Maher","year":"2016","unstructured":"Maher S, Mrsny RJ, Brayden DJ. Intestinal permeation enhancers for oral peptide delivery. Adv Drug Deliv Rev. 2016;106:277\u2013319. https:\/\/doi.org\/10.1016\/J.ADDR.2016.06.005.","journal-title":"Adv Drug Deliv Rev"},{"issue":"4","key":"1760_CR5","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/S41573-019-0053-0","volume":"19","author":"DJ Drucker","year":"2020","unstructured":"Drucker DJ. Advances in oral peptide therapeutics. Nat Rev Drug Discov. 2020;19(4):277\u201389. https:\/\/doi.org\/10.1038\/S41573-019-0053-0.","journal-title":"Nat Rev Drug Discov"},{"key":"1760_CR6","doi-asserted-by":"publisher","unstructured":"Haddadzadegan S, Dorkoosh F, Bernkop-Schn\u00fcrch A. Oral delivery of therapeutic peptides and proteins: Technology landscape of lipid-based nanocarriers. Adv Drug Deliv Rev 2022;182, https:\/\/doi.org\/10.1016\/J.ADDR.2021.114097.","DOI":"10.1016\/J.ADDR.2021.114097"},{"key":"1760_CR7","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/J.JCONREL.2014.08.004","volume":"192","author":"I Pereira De Sousa","year":"2014","unstructured":"Pereira De Sousa I, Bernkop-Schn\u00fcrch A. Pre-systemic metabolism of orally administered drugs and strategies to overcome it. J Control Release. 2014;192:301\u20139. https:\/\/doi.org\/10.1016\/J.JCONREL.2014.08.004.","journal-title":"J Control Release"},{"issue":"3","key":"1760_CR8","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1080\/17425247.2017.1395853","volume":"15","author":"C Liu","year":"2018","unstructured":"Liu C, Kou Y, Zhang X, Cheng H, Chen X, Mao S. Strategies and industrial perspectives to improve oral absorption of biological macromolecules. Expert Opin Drug Deliv. 2018;15(3):223\u201333. https:\/\/doi.org\/10.1080\/17425247.2017.1395853.","journal-title":"Expert Opin Drug Deliv"},{"key":"1760_CR9","doi-asserted-by":"publisher","unstructured":"Dan N, Samanta K, Almoazen H. An update on pharmaceutical strategies for oral delivery of therapeutic peptides and proteins in adults and pediatrics. 2020. https:\/\/doi.org\/10.3390\/children7120307.","DOI":"10.3390\/children7120307"},{"key":"1760_CR10","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.addr.2018.07.001","volume":"142","author":"A Mahmood","year":"2019","unstructured":"Mahmood A, Bernkop-Schn\u00fcrch A. SEDDS: A game changing approach for the oral administration of hydrophilic macromolecular drugs. Adv Drug Deliv Rev. 2019;142:91\u2013101. https:\/\/doi.org\/10.1016\/j.addr.2018.07.001.","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"1760_CR11","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.ijpharm.2017.03.027","volume":"523","author":"G Het\u00e9nyi","year":"2017","unstructured":"Het\u00e9nyi G, Griesser J, Moser M, Demarne F, Jannin V, Bernkop-Schn\u00fcrch A. Comparison of the protective effect of self-emulsifying peptide drug delivery systems towards intestinal proteases and glutathione. Int J Pharm. 2017;523(1):357\u201365. https:\/\/doi.org\/10.1016\/j.ijpharm.2017.03.027.","journal-title":"Int J Pharm"},{"issue":"1\u20132","key":"1760_CR12","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/J.IJPHARM.2018.01.018","volume":"538","author":"J Griesser","year":"2018","unstructured":"Griesser J, Het\u00e9nyi G, Kadas H, Demarne F, Jannin V, Bernkop-Schn\u00fcrch A. Self-emulsifying peptide drug delivery systems: How to make them highly mucus permeating. Int J Pharm. 2018;538(1\u20132):159\u201366. https:\/\/doi.org\/10.1016\/J.IJPHARM.2018.01.018.","journal-title":"Int J Pharm"},{"issue":"11","key":"1760_CR13","doi-asserted-by":"publisher","first-page":"4207","DOI":"10.1039\/c9na00308h","volume":"1","author":"KD Ristroph","year":"2019","unstructured":"Ristroph KD, Prud\u2019homme RK. Hydrophobic ion pairing: Encapsulating small molecules, peptides, and proteins into nanocarriers. Nanoscale Adv. 2019;1(11):4207\u201337. https:\/\/doi.org\/10.1039\/c9na00308h.","journal-title":"Nanoscale Adv"},{"issue":"2","key":"1760_CR14","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1023\/A:1011998014474\/METRICS","volume":"15","author":"JD Meyer","year":"1998","unstructured":"Meyer JD, Manning MC. Hydrophobic ion pairing: Altering the solubility properties of biomolecules. Pharm Res. 1998;15(2):188\u201393. https:\/\/doi.org\/10.1023\/A:1011998014474\/METRICS.","journal-title":"Pharm Res"},{"key":"1760_CR15","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.ejpb.2020.09.007","volume":"156","author":"A Gamboa","year":"2020","unstructured":"Gamboa A, Sch\u00fc\u00dfler N, Soto-Bustamante E, Romero-Hasler P, Meinel L, Morales JO. Delivery of ionizable hydrophilic drugs based on pharmaceutical formulation of ion pairs and ionic liquids. Eur J Pharm Biopharm. 2020;156:203\u201318. https:\/\/doi.org\/10.1016\/j.ejpb.2020.09.007.","journal-title":"Eur J Pharm Biopharm"},{"issue":"2","key":"1760_CR16","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/0300-483X(92)90162-8","volume":"76","author":"RL Grant","year":"1992","unstructured":"Grant RL, Yao C, Gabaldon D, Acosta D. Evaluation of surfactant cytotoxicity potential by primary cultures of ocular tissues: I. Characterization of rabbit corneal epithelial cells and initial injury and delayed toxicity studies. Toxicology. 1992;76(2):153\u201376. https:\/\/doi.org\/10.1016\/0300-483X(92)90162-8.","journal-title":"Toxicology"},{"issue":"2","key":"1760_CR17","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/J.COLSURFB.2008.12.038","volume":"70","author":"N Vlachy","year":"2009","unstructured":"Vlachy N, Touraud D, Heilmann J, Kunz W. Determining the cytotoxicity of catanionic surfactant mixtures on HeLa cells. Colloids Surf B Biointerfaces. 2009;70(2):278\u201380. https:\/\/doi.org\/10.1016\/J.COLSURFB.2008.12.038.","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"32","key":"1760_CR18","doi-asserted-by":"publisher","first-page":"11173","DOI":"10.1073\/PNAS.0502416102","volume":"102","author":"H Liang","year":"2005","unstructured":"Liang H, Harries D, Wong GCL. Polymorphism of DNA-anionic liposome complexes reveals hierarchy of ion-mediated interactions. Proc Natl Acad Sci U S A. 2005;102(32):11173\u20138. https:\/\/doi.org\/10.1073\/PNAS.0502416102.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1760_CR19","doi-asserted-by":"publisher","first-page":"103459","DOI":"10.1016\/J.JMBBM.2019.103459","volume":"102","author":"E Komorowicz","year":"2020","unstructured":"Komorowicz E, et al. Biorelevant polyanions stabilize fibrin against mechanical and proteolytic decomposition: Effects of polymer size and electric charge. J Mech Behav Biomed Mater. 2020;102:103459. https:\/\/doi.org\/10.1016\/J.JMBBM.2019.103459.","journal-title":"J Mech Behav Biomed Mater"},{"key":"1760_CR20","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/J.IJBIOMAC.2022.03.144","volume":"208","author":"G Iyer","year":"2022","unstructured":"Iyer G, Dyawanapelly S, Jain R, Dandekar P. An overview of oral insulin delivery strategies (OIDS). Int J Biol Macromol. 2022;208:565\u201385. https:\/\/doi.org\/10.1016\/J.IJBIOMAC.2022.03.144.","journal-title":"Int J Biol Macromol"},{"key":"1760_CR21","doi-asserted-by":"publisher","first-page":"726675","DOI":"10.3389\/FDDEV.2021.726675","volume":"1","author":"DJ Brayden","year":"2021","unstructured":"Brayden DJ. The centenary of the discovery of insulin: an update on the quest for oral delivery. Front Drug Deliv. 2021;1:726675. https:\/\/doi.org\/10.3389\/FDDEV.2021.726675.","journal-title":"Front Drug Deliv"},{"issue":"7","key":"1760_CR22","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1517\/14656566.2011.570261","volume":"12","author":"Z Iqbal","year":"2011","unstructured":"Iqbal Z, Cohen M. Enoxaparin: a pharmacologic and clinical review. Expert Opin Pharmacother. 2011;12(7):1157\u201370. https:\/\/doi.org\/10.1517\/14656566.2011.570261.","journal-title":"Expert Opin Pharmacother"},{"key":"1760_CR23","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.chemphys.2012.11.023","volume":"422","author":"ML Donten","year":"2013","unstructured":"Donten ML, Hamm P. pH-jump induced \u03b1-helix folding of poly-l-glutamic acid. Chem Phys. 2013;422:124\u201330. https:\/\/doi.org\/10.1016\/j.chemphys.2012.11.023.","journal-title":"Chem Phys"},{"issue":"16","key":"1760_CR24","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1002\/CPHC.202000162","volume":"21","author":"O Matsarskaia","year":"2020","unstructured":"Matsarskaia O, Roosen-Runge F, Schreiber F. Multivalent ions and biomolecules: attempting a comprehensive perspective. ChemPhysChem. 2020;21(16):1742\u201367. https:\/\/doi.org\/10.1002\/CPHC.202000162.","journal-title":"ChemPhysChem"},{"issue":"1","key":"1760_CR25","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1515\/acph-2015-0010","volume":"65","author":"MR Matanovi\u0107","year":"2015","unstructured":"Matanovi\u0107 MR, Grabnarm I, Grabnar PA, Ro\u0161kar R. Development and validation of a simple and sensitive size-exclusion chromatography method for quantitative determination of heparin in pharmaceuticals. Acta Pharm. 2015;65(1):43\u201352. https:\/\/doi.org\/10.1515\/acph-2015-0010.","journal-title":"Acta Pharm"},{"key":"1760_CR26","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/J.EJPB.2020.04.004","volume":"151","author":"R Wibel","year":"2020","unstructured":"Wibel R, Friedl JD, Zaichik S, Bernkop-Schn\u00fcrch A. Hydrophobic ion pairing (HIP) of (poly)peptide drugs: Benefits and drawbacks of different preparation methods. Eur J Pharm Biopharm. 2020;151:73\u201380. https:\/\/doi.org\/10.1016\/J.EJPB.2020.04.004.","journal-title":"Eur J Pharm Biopharm"},{"key":"1760_CR27","doi-asserted-by":"publisher","first-page":"104686","DOI":"10.1016\/J.JDDST.2023.104686","volume":"86","author":"K Z\u00f6ller","year":"2023","unstructured":"Z\u00f6ller K, Laffleur F, Claus V, Knoll P, To D, Bernkop-Schn\u00fcrch A. Development and in vivo evaluation of nanoemulsions for oral delivery of low molecular weight heparin. J Drug Deliv Sci Technol. 2023;86:104686. https:\/\/doi.org\/10.1016\/J.JDDST.2023.104686.","journal-title":"J Drug Deliv Sci Technol"},{"key":"1760_CR28","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.ijpharm.2019.03.001","volume":"561","author":"I Nazir","year":"2019","unstructured":"Nazir I, Asim MH, Dizdarevi\u0107 A, Bernkop-Schn\u00fcrch A. Self-emulsifying drug delivery systems: Impact of stability of hydrophobic ion pairs on drug release. Int J Pharm. 2019;561:197\u2013205. https:\/\/doi.org\/10.1016\/j.ijpharm.2019.03.001.","journal-title":"Int J Pharm"},{"key":"1760_CR29","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/J.EJPB.2016.09.013","volume":"109","author":"O Zupan\u010di\u010d","year":"2016","unstructured":"Zupan\u010di\u010d O, et al. Development, in vitro and in vivo evaluation of a self-emulsifying drug delivery system (SEDDS) for oral enoxaparin administration. Eur J Pharm Biopharm. 2016;109:113\u201321. https:\/\/doi.org\/10.1016\/J.EJPB.2016.09.013.","journal-title":"Eur J Pharm Biopharm"},{"issue":"3","key":"1760_CR30","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1208\/s12249-020-1618-2","volume":"21","author":"NE Eleraky","year":"2020","unstructured":"Eleraky NE, Swarnakar NK, Mohamed DF, Attia MA, Pauletti GM. Permeation-Enhancing Nanoparticle Formulation to Enable Oral Absorption of Enoxaparin. AAPS PharmSciTech. 2020;21(3):88. https:\/\/doi.org\/10.1208\/s12249-020-1618-2.","journal-title":"AAPS PharmSciTech"},{"issue":"4","key":"1760_CR31","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/BF01918191","volume":"24","author":"F Hofmeister","year":"1888","unstructured":"Hofmeister F. Zur Lehre von der Wirkung der Salze. Archiv f\u00fcr experimentelle Pathologie und Pharmakologie. 1888;24(4):247\u201360. https:\/\/doi.org\/10.1007\/BF01918191.","journal-title":"Archiv f\u00fcr experimentelle Pathologie und Pharmakologie"},{"issue":"25","key":"1760_CR32","doi-asserted-by":"publisher","first-page":"7389","DOI":"10.1021\/jp212243c","volume":"116","author":"J Kherb","year":"2012","unstructured":"Kherb J, Flores SC, Cremer PS. Role of Carboxylate Side Chains in the Cation Hofmeister Series. J Phys Chem B. 2012;116(25):7389\u201397. https:\/\/doi.org\/10.1021\/jp212243c.","journal-title":"J Phys Chem B"},{"issue":"1","key":"1760_CR33","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/0021-9797(85)90079-7","volume":"103","author":"H Ohshima","year":"1985","unstructured":"Ohshima H, Ohki S. Effects of divalent cations on the surface tension of a lipid monolayer-coated air\/water interface. J Colloid Interface Sci. 1985;103(1):85\u201394. https:\/\/doi.org\/10.1016\/0021-9797(85)90079-7.","journal-title":"J Colloid Interface Sci"},{"issue":"8","key":"1760_CR34","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1021\/ACS.JPCB.6B11443\/ASSET\/IMAGES\/LARGE\/JP-2016-11443W_0007.JPEG","volume":"121","author":"A Das","year":"2017","unstructured":"Das A, Adhikari C, Chakraborty A. Interaction of different divalent metal ions with lipid bilayer: impact on the encapsulation of doxorubicin by lipid bilayer and lipoplex mediated deintercalation. J Phys Chem B. 2017;121(8):1854\u201365. https:\/\/doi.org\/10.1021\/ACS.JPCB.6B11443\/ASSET\/IMAGES\/LARGE\/JP-2016-11443W_0007.JPEG.","journal-title":"J Phys Chem B"},{"key":"1760_CR35","doi-asserted-by":"publisher","unstructured":"Jakubowska A. Interactions of divalent metal cations with headgroups of monomers, dimers, and trimers of anionic surfactant. J Mol Liq 2021;336, https:\/\/doi.org\/10.1016\/J.MOLLIQ.2021.116331.","DOI":"10.1016\/J.MOLLIQ.2021.116331"},{"issue":"2","key":"1760_CR36","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/0009-3084(94)90055-8","volume":"74","author":"G Steffan","year":"1994","unstructured":"Steffan G, Wulff S, Galla H-J. Divalent cation-dependent interaction of sulfated polysaccharides with phosphatidylcholine and mixed phosphatidylcholine\/phosphatidylglycerol liposomes. Chem Phys Lipids. 1994;74(2):141\u201350. https:\/\/doi.org\/10.1016\/0009-3084(94)90055-8.","journal-title":"Chem Phys Lipids"},{"issue":"1\u20132","key":"1760_CR37","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/J.IJPHARM.2017.02.019","volume":"520","author":"J Griesser","year":"2017","unstructured":"Griesser J, Het\u00e9nyi G, Moser M, Demarne F, Jannin V, Bernkop-Schn\u00fcrch A. Hydrophobic ion pairing: key to highly payloaded self-emulsifying peptide drug delivery systems. Int J Pharm. 2017;520(1\u20132):267\u201374. https:\/\/doi.org\/10.1016\/J.IJPHARM.2017.02.019.","journal-title":"Int J Pharm"},{"key":"1760_CR38","doi-asserted-by":"publisher","unstructured":"Mudassir J et al. Design and evaluation of hydrophobic Ion paired insulin loaded self micro-emulsifying drug delivery system for oral delivery. Pharmaceutics 2023;15(7), https:\/\/doi.org\/10.3390\/pharmaceutics15071973.","DOI":"10.3390\/pharmaceutics15071973"},{"key":"1760_CR39","doi-asserted-by":"publisher","unstructured":"Tae Goo Y et al. Enhanced oral absorption of insulin: hydrophobic ion pairing and a self-microemulsifying drug delivery system using a D-optimal mixture design. Drug Deliv 2022(1): 2831\u20132845, https:\/\/doi.org\/10.1080\/10717544.2022.2118399.","DOI":"10.1080\/10717544.2022.2118399"},{"issue":"41","key":"1760_CR40","doi-asserted-by":"publisher","first-page":"24014","DOI":"10.1039\/D0CP02987D","volume":"22","author":"D de Oliveira","year":"2020","unstructured":"de Oliveira D, et al. Binding of divalent cations to acetate: molecular simulations guided by Raman spectroscopy. Phys Chem Chem Phys. 2020;22(41):24014\u201327. https:\/\/doi.org\/10.1039\/D0CP02987D.","journal-title":"Phys Chem Chem Phys"},{"issue":"3","key":"1760_CR41","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1021\/cr020467n","volume":"103","author":"T Dudev","year":"2003","unstructured":"Dudev T, Lim C. Principles governing Mg, Ca, and Zn binding and selectivity in proteins. Chem Rev. 2003;103(3):773\u201388. https:\/\/doi.org\/10.1021\/cr020467n.","journal-title":"Chem Rev"},{"key":"1760_CR42","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1146\/annurev.biophys.37.032807.125811","volume":"37","author":"T Dudev","year":"2008","unstructured":"Dudev T, Lim C. Metal binding affinity and selectivity in metalloproteins: insights from computational studies. Annu Rev Biophys. 2008;37:97\u2013116.","journal-title":"Annu Rev Biophys"},{"issue":"21","key":"1760_CR43","doi-asserted-by":"publisher","first-page":"5640","DOI":"10.1021\/ACS.JPCB.7B12097\/SUPPL_FILE\/JP7B12097_SI_001.PDF","volume":"122","author":"E Dubou\u00e9-Dijon","year":"2018","unstructured":"Dubou\u00e9-Dijon E, et al. Binding of divalent cations to insulin: capillary electrophoresis and molecular simulations. J Phys Chem B. 2018;122(21):5640\u20138. https:\/\/doi.org\/10.1021\/ACS.JPCB.7B12097\/SUPPL_FILE\/JP7B12097_SI_001.PDF.","journal-title":"J Phys Chem B"},{"key":"1760_CR44","doi-asserted-by":"publisher","first-page":"122964","DOI":"10.1016\/J.IJPHARM.2023.122964","volume":"639","author":"V Claus","year":"2023","unstructured":"Claus V, et al. Self-emulsifying drug delivery systems (SEDDS): In vivo-proof of concept for oral delivery of insulin glargine. Int J Pharm. 2023;639:122964. https:\/\/doi.org\/10.1016\/J.IJPHARM.2023.122964.","journal-title":"Int J Pharm"},{"key":"1760_CR45","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/J.ADDR.2018.10.014","volume":"142","author":"I Nardin","year":"2019","unstructured":"Nardin I, K\u00f6llner S. Successful development of oral SEDDS: screening of excipients from the industrial point of view. Adv Drug Deliv Rev. 2019;142:128\u201340. https:\/\/doi.org\/10.1016\/J.ADDR.2018.10.014.","journal-title":"Adv Drug Deliv Rev"},{"issue":"9","key":"1760_CR46","doi-asserted-by":"publisher","first-page":"3236","DOI":"10.1021\/acs.molpharmaceut.0c00343","volume":"17","author":"AM J\u00f6rgensen","year":"2020","unstructured":"J\u00f6rgensen AM, Friedl JD, Wibel R, Chamieh J, Cottet H, Bernkop-Schn\u00fcrch A. Cosolvents in Self-Emulsifying Drug Delivery Systems (SEDDS): do they really solve our solubility problems? Mol Pharm. 2020;17(9):3236\u201345. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.0c00343.","journal-title":"Mol Pharm"},{"issue":"1","key":"1760_CR47","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/S0928-0987(03)00174-X","volume":"20","author":"R Holm","year":"2003","unstructured":"Holm R, Porter CJH, Edwards GA, M\u00fcllertz A, Kristensen HG, Charman WN. Examination of oral absorption and lymphatic transport of halofantrine in a triple-cannulated canine model after administration in self-microemulsifying drug delivery systems (SMEDDS) containing structured triglycerides. Eur J Pharm Sci. 2003;20(1):91\u20137. https:\/\/doi.org\/10.1016\/S0928-0987(03)00174-X.","journal-title":"Eur J Pharm Sci"},{"key":"1760_CR48","doi-asserted-by":"publisher","first-page":"119201","DOI":"10.1016\/J.IJPHARM.2020.119201","volume":"580","author":"D Izgelov","year":"2020","unstructured":"Izgelov D, Shmoeli E, Domb AJ, Hoffman A. The effect of medium chain and long chain triglycerides incorporated in self-nano emulsifying drug delivery systems on oral absorption of cannabinoids in rats. Int J Pharm. 2020;580:119201. https:\/\/doi.org\/10.1016\/J.IJPHARM.2020.119201.","journal-title":"Int J Pharm"},{"key":"1760_CR49","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/J.COLSURFB.2012.05.019","volume":"100","author":"S Bandyopadhyay","year":"2012","unstructured":"Bandyopadhyay S, Katare OP, Singh B. Optimized self nano-emulsifying systems of ezetimibe with enhanced bioavailability potential using long chain and medium chain triglycerides. Colloids Surf B Biointerfaces. 2012;100:50\u201361. https:\/\/doi.org\/10.1016\/J.COLSURFB.2012.05.019.","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"5","key":"1760_CR50","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1016\/J.XPHS.2020.01.031","volume":"109","author":"HH Desai","year":"2020","unstructured":"Desai HH, Bu P, Shah AV, Cheng X, Serajuddin ATM. Evaluation of cytotoxicity of self-emulsifying formulations containing long-chain lipids using Caco-2 Cell Model: superior safety profile compared to medium-chain lipids. J Pharm Sci. 2020;109(5):1752\u201364. https:\/\/doi.org\/10.1016\/J.XPHS.2020.01.031.","journal-title":"J Pharm Sci"},{"issue":"3","key":"1760_CR51","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/J.EJPS.2006.02.005","volume":"28","author":"M Grove","year":"2006","unstructured":"Grove M, M\u00fcllertz A, Nielsen JL, Pedersen GP. Bioavailability of seocalcitol: II: Development and characterisation of self-microemulsifying drug delivery systems (SMEDDS) for oral administration containing medium and long chain triglycerides. Eur J Pharm Sci. 2006;28(3):233\u201342. https:\/\/doi.org\/10.1016\/J.EJPS.2006.02.005.","journal-title":"Eur J Pharm Sci"},{"issue":"4","key":"1760_CR52","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1016\/j.xphs.2019.12.012","volume":"109","author":"H Ukai","year":"2020","unstructured":"Ukai H, Kawagoe A, Sato E, Morishita M, Katsumi H, Yamamoto A. Propylene glycol caprylate as a novel potential absorption enhancer for improving the intestinal absorption of insulin: efficacy, safety, and absorption-enhancing mechanisms. J Pharm Sci. 2020;109(4):1483\u201392. https:\/\/doi.org\/10.1016\/j.xphs.2019.12.012.","journal-title":"J Pharm Sci"},{"key":"1760_CR53","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/J.JCONREL.2019.08.008","volume":"310","author":"F McCartney","year":"2019","unstructured":"McCartney F, et al. Labrasol\u00ae is an efficacious intestinal permeation enhancer across rat intestine: ex vivo and in vivo rat studies. J Control Release. 2019;310:115\u201326. https:\/\/doi.org\/10.1016\/J.JCONREL.2019.08.008.","journal-title":"J Control Release"},{"issue":"5","key":"1760_CR54","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/J.EJPS.2005.01.001","volume":"24","author":"X Sha","year":"2005","unstructured":"Sha X, Yan G, Wu Y, Li J, Fang X. Effect of self-microemulsifying drug delivery systems containing Labrasol on tight junctions in Caco-2 cells. Eur J Pharm Sci. 2005;24(5):477\u201386. https:\/\/doi.org\/10.1016\/J.EJPS.2005.01.001.","journal-title":"Eur J Pharm Sci"},{"issue":"6","key":"1760_CR55","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1016\/J.XPHS.2018.02.012","volume":"107","author":"J Heade","year":"2018","unstructured":"Heade J, Maher S, Bleiel SB, Brayden DJ. Labrasol\u00ae and salts of medium-chain fatty acids can be combined in low concentrations to increase the permeability of a macromolecule marker across isolated rat intestinal mucosae. J Pharm Sci. 2018;107(6):1648\u201355. https:\/\/doi.org\/10.1016\/J.XPHS.2018.02.012.","journal-title":"J Pharm Sci"},{"key":"1760_CR56","doi-asserted-by":"publisher","first-page":"S93","DOI":"10.1016\/S0928-0987(00)00167-6","volume":"11","author":"CW Pouton","year":"2000","unstructured":"Pouton CW. Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and \u2018self-microemulsifying\u2019 drug delivery systems. Eur J Pharm Sci. 2000;11:S93\u20138. https:\/\/doi.org\/10.1016\/S0928-0987(00)00167-6.","journal-title":"Eur J Pharm Sci"},{"key":"1760_CR57","doi-asserted-by":"publisher","first-page":"3213","DOI":"10.1021\/acs.molpharmaceut.0c00305","volume":"17","author":"NJ Koehl","year":"2020","unstructured":"Koehl NJ, Ren\u00e9holm R, Kuentz M, Jannin V, Griffin BT. Exploring the impact of surfactant type and digestion: highly digestible surfactants improve oral bioavailability of nilotinib. Cite This Mol Pharmaceutics. 2020;17:3213. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.0c00305.","journal-title":"Cite This Mol Pharmaceutics"},{"issue":"12","key":"1760_CR58","doi-asserted-by":"publisher","first-page":"4406","DOI":"10.1002\/JPS.23757","volume":"102","author":"H Friedl","year":"2013","unstructured":"Friedl H, et al. Development and evaluation of a novel mucus diffusion test system approved by self-nanoemulsifying drug delivery systems. J Pharm Sci. 2013;102(12):4406\u201313. https:\/\/doi.org\/10.1002\/JPS.23757.","journal-title":"J Pharm Sci"},{"key":"1760_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/J.EJPB.2017.11.003","volume":"123","author":"T Vasconcelos","year":"2018","unstructured":"Vasconcelos T, Marques S, Sarmento B. Measuring the emulsification dynamics and stability of self-emulsifying drug delivery systems. Eur J Pharm Biopharm. 2018;123:1\u20138. https:\/\/doi.org\/10.1016\/J.EJPB.2017.11.003.","journal-title":"Eur J Pharm Biopharm"},{"key":"1760_CR60","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/J.JCONREL.2017.12.027","volume":"271","author":"A Bernkop-Schn\u00fcrch","year":"2018","unstructured":"Bernkop-Schn\u00fcrch A, Jalil A. Do drug release studies from SEDDS make any sense? J Control Release. 2018;271:55\u20139. https:\/\/doi.org\/10.1016\/J.JCONREL.2017.12.027.","journal-title":"J Control Release"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-024-01760-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13346-024-01760-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-024-01760-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T16:44:51Z","timestamp":1751388291000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13346-024-01760-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,17]]},"references-count":60,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["1760"],"URL":"https:\/\/doi.org\/10.1007\/s13346-024-01760-1","relation":{},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,17]]},"assertion":[{"value":"22 November 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare the following financial interests\/personal relationships which may be considered as potential competing interests: Andreas Bernkop-Schn\u00fcrch reports financial support was provided by Johnson & Johnson Innovative Medicine. Dajun Sun, Nathaniel Washburn, Cecilia Bohns Michalowski and Giustino Di Pretoro report a relationship with Johnson & Johnson Innovative Medicine that includes: employment.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}]}}